LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-1.88 Cr | ₹-4.50 Cr | ₹-0.70 Cr | ₹6.77 Cr | ₹-1.11 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LINCOLN PHARMACEUTICALS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2023 | ₹-1.88 Cr |
Mar2022 | ₹-4.50 Cr |
Mar2021 | ₹-0.70 Cr |
Mar2020 | ₹6.77 Cr |
Mar2019 | ₹-1.11 Cr |
How is Net Cash Inflow / Outflow of LINCOLN PHARMACEUTICALS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2023 | ₹-1.88 Cr | Negative | |
Mar2022 | ₹-4.50 Cr | Negative | |
Mar2021 | ₹-0.70 Cr | Negative | |
Mar2020 | ₹6.77 Cr | Positive | |
Mar2019 | ₹-1.11 Cr | - |
Compare Net Cash Inflow / Outflow of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,209.3 Cr | 2% | 2% | 52.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | 2% |
2% |
52.2% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses